BPCE
ABMD

Bank Pictet & Cie (Europe)’s Abiomed Inc ABMD Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,181
Closed -$290K – 175
2022
Q3 		$290K Hold
1,181
– – 0.01% 144
2022
Q2 		$292K Sell
1,181
-295
-20% -$79.6K 0.01% 136
2022
Q1 		$489K Sell
1,476
-389
-21% -$120K 0.02% 124
2021
Q4 		$670K Buy
1,865
+197
+12% +$66.6K 0.02% 123
2021
Q3 		$543K Sell
1,668
-156
-9% -$52.8K 0.02% 129
2021
Q2 		$569K Buy
1,824
+268
+17% +$82.2K 0.02% 133
2021
Q1 		$496K Buy
+1,556
New +$498K 0.02% 126

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s ABMD Position: Q4 2022 in Review

Bank Pictet & Cie (Europe) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,181 shares — an estimated $290K sold.

Bank Pictet & Cie (Europe) first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $670K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bank Pictet & Cie (Europe) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 1,181 Abiomed Inc shares in Q4 2022, an estimated $290K.
  • Bank Pictet & Cie (Europe) first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • Bank Pictet & Cie (Europe)'s Abiomed Inc position peaked at $670K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.